Navigation Links
International Travelers Can Say Good-Bye to 'Montezuma's Revenge' With Launch of Travelan(R) in the U.S. From Alaven Consumer Healthcare
Date:4/13/2009

MARIETTA, Ga., April 13 /PRNewswire/ -- Travelan(R), a natural, clinically-tested oral formulation containing antibodies against Enterotoxigenic E.coli (ETEC) bacteria attacks, is now available in the U.S. through Alaven Consumer Healthcare. E.coli (ETEC) is most frequently found in tourist destinations such as Mexico, Latin America, South America, India, Asia, the Middle East and Africa.

Travelan is the only non-prescription product specifically formulated to reduce the risk of Montezuma's Revenge.

Infection with E.coli (ETEC) is the leading cause of travelers' diarrhea (TD) - often referred to as "Montezuma's Revenge," "Delhi Belly," "Bali Belly" or "Traveler's Trots" - and is the most common illness affecting travelers.(1) According to the Centers for Disease Control and Prevention (CDC), each year between 20-50 percent of international travelers - an estimated 10 million people - develop diarrhea while traveling.(2)

E.coli (ETEC) produces toxins that stimulate the lining of the intestines to secrete excessive fluid.(3) In a controlled, double-blind, clinical study, Travelan provided 93 percent protection against E.coli (ETEC).

One Travelan caplet is taken before each meal one day prior to and during travel to neutralize the harmful E.coli (ETEC) bacteria, which inhibits them from attaching to the intestinal wall.

E.coli (ETEC) is acquired through food, water or ice contaminated with the bacteria including tap water; food or drinks prepared in unhygienic conditions, including street vendors; raw or undercooked meat and seafood; raw fruits and vegetables (unless peeled by the traveler); and unpasteurized milk and dairy products.(4)

"Whether you're an adventure traveler, you're taking the family on that long-awaited vacation or honeymooning, you want to spend your time seeing the sights and enjoying time off, not being sick," said David Swenson, general manager and head of Alaven Consumer Healthcare. "Travelan helps you make the most of your travels by preventing E.coli (ETEC) infection, not just treating it after it occurs."

Travelan is available in single, family, honeymoon and group packs through www.travelan.org or 1-800-470-7902 for $49.99 for 30 caplets, which is less than $5 a day for a 10-day trip. Travelan has been available in Australia since 2006 and has been used by over 100,000 travelers. Alaven Consumer Healthcare established a North American distribution agreement and strategic investment with Immuron of Australia in December 2008.

About Alaven Consumer Healthcare, Inc.

Alaven Consumer Healthcare, Inc. is a privately-held consumer health company located in Marietta, Ga., and a sister company to Alaven Pharmaceutical LLC, which develops and markets gastroenterological and women's health prescription products. Among the products Alaven Consumer Healthcare manufactures and distributes are Travelan(R), Balneol(R), Bifera(TM) and UniFiber(R).

(1) Centers for Disease Control and Prevention, Disease Listings, Enterotoxigenic Escherichia coli (ETEC), Frequently Asked Questions, www.cdc.gov/ncidod/dbmd/diseaseinfo/etec_g.htm#whatis, accessed March 31, 2009

(2) Centers for Disease Control and Prevention, Disease Listings, Travelers' Diarrhea, www.cdc.gov/ncidod/dbmd/diseaseinfo/travelersdiarrhea_g.htm, accessed March 31, 2009

(3) Centers for Disease Control and Prevention, Disease Listings, Enterotoxigenic Escherichia coli (ETEC), Frequently Asked Questions, www.cdc.gov/ncidod/dbmd/diseaseinfo/etec_g.htm#whatis, accessed March 31, 2009

(4) Centers for Disease Control and Prevention, Disease Listings, Travelers' Diarrhea, www.cdc.gov/ncidod/dbmd/diseaseinfo/travelersdiarrhea_g.htm, accessed March 31, 2009


'/>"/>
SOURCE Alaven Consumer Healthcare, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... San Francisco, CA (PRWEB) , ... March 28, 2017 , ... ... restoration treatment, is proud to announce a new blog post about women’s hair loss. ... women suffer from hair loss as they age. Menopause or genetics can be two ...
(Date:3/28/2017)... Louis, MO (PRWEB) , ... March 28, 2017 ... ... levels of job satisfaction in their profession as their value increases in the ... company that provides resources such as job boards, career fairs, and candidate leads ...
(Date:3/27/2017)... ... 27, 2017 , ... New patients who have sleep apnea in ... or without a referral. Sleep apnea is often left untreated because patients are not ... and chronic snoring. , Dr. Braasch seeks to raise awareness of sleep apnea ...
(Date:3/27/2017)... ... March 27, 2017 , ... New patients who want to experience the benefits ... now have them placed by Dr. Manju Kejriwal, with or without a referral. Dr. ... increase the accuracy of each dental implant placement. The i-CAT CBCT system captures the ...
(Date:3/27/2017)... ... March 27, 2017 , ... This ... OSEHRA popHealth Community in 2014. It is the culmination of collaborative ... Open Source Project Group. OSEHRA Organizational Member Zato Health co-funded the ONC certification ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017   Pulmatrix, Inc . (NASDAQ: ... to address serious pulmonary diseases, today announced that it has ... cystic fibrosis and asthma to its Scientific Advisory Board ... Richard B. Moss , MD, former chief of ... the Cystic Fibrosis Center at Stanford University, and ...
(Date:3/27/2017)... , March 27, 2017 On ... the NASDAQ Composite closed the trading session up 0.19%; ... the S&P 500 was down 0.08%. US markets made ... finishing the day in green. Pre-market today, Stock-Callers.com reviews ... Group N.V. (NASDAQ: WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx ...
(Date:3/27/2017)... March 27, 2017  Impax Laboratories, Inc. (NASDAQ: IPXL)today ... Paul M. Bisaro as Impax,s President and Chief ... effective March 27, 2017. Mr. Bisaro will succeed ... President and Chief Executive Officer since December of 2016. ... branded pharmaceutical experience, Mr. Bisaro, 56, is an accomplished ...
Breaking Medicine Technology: